Impact of the Hepatic Branch of the Vagus Nerve Transection in Laparoscopic Sleeve Gastrectomy for Patients with Obesity and Type 2 Diabetes Mellitus.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
09 2021
Historique:
received: 26 02 2021
accepted: 26 05 2021
revised: 23 05 2021
pubmed: 4 6 2021
medline: 28 9 2021
entrez: 3 6 2021
Statut: ppublish

Résumé

An increase in gastroesophageal reflux disease (GERD) after laparoscopic sleeve gastrectomy (LSG) has been reported, and concomitant hiatal hernia repair (HHR) during LSG is expected to reduce the incidence of post-LSG GERD. In HHR, the hepatic branch of the vagus nerve is anatomically transected. Recent experimental animal models suggest that vagotomy may affect glycemic control and weight loss through a neuroendocrine response. To examine whether LSG with/without hepatic branch vagotomy (HV) has a clinical impact on glycemic control in patients with obesity and type 2 diabetes mellitus (T2DM). Furthermore, the impact on weight loss and post-LSG GERD were evaluated. A total of 204 Japanese patients with obesity and T2DM, who underwent LSG and completed 1-year follow-up, were retrospectively analyzed. Operative outcomes, weight loss, glycemic, and GERD-related parameters were compared between the LSG/HHR/HV group (n = 89) and the LSG group (n = 115). There was no significant difference in the background factors in terms of anthropometric and T2DM-related parameters between the groups. The median operation times in the LSG/HHR/HV and LSG groups were 133 and 124 minutes, respectively (p = 0.236). At 1 year, the diabetes remission rate, HbA1c, fasting glucose, and C-peptide levels were all comparable between the groups. The weight loss effect was also comparable. The patients in the LSG/HHR/HV group achieved significant improvement and prevention of GERD and hiatus hernia (p < 0.001). HV does not appear to have a clinical impact on glycemic control and weight loss. Concomitant HHR with LSG serves to reduce post-LSG GERD.

Sections du résumé

BACKGROUND
An increase in gastroesophageal reflux disease (GERD) after laparoscopic sleeve gastrectomy (LSG) has been reported, and concomitant hiatal hernia repair (HHR) during LSG is expected to reduce the incidence of post-LSG GERD. In HHR, the hepatic branch of the vagus nerve is anatomically transected. Recent experimental animal models suggest that vagotomy may affect glycemic control and weight loss through a neuroendocrine response.
OBJECTIVES
To examine whether LSG with/without hepatic branch vagotomy (HV) has a clinical impact on glycemic control in patients with obesity and type 2 diabetes mellitus (T2DM). Furthermore, the impact on weight loss and post-LSG GERD were evaluated.
METHODS
A total of 204 Japanese patients with obesity and T2DM, who underwent LSG and completed 1-year follow-up, were retrospectively analyzed. Operative outcomes, weight loss, glycemic, and GERD-related parameters were compared between the LSG/HHR/HV group (n = 89) and the LSG group (n = 115).
RESULTS
There was no significant difference in the background factors in terms of anthropometric and T2DM-related parameters between the groups. The median operation times in the LSG/HHR/HV and LSG groups were 133 and 124 minutes, respectively (p = 0.236). At 1 year, the diabetes remission rate, HbA1c, fasting glucose, and C-peptide levels were all comparable between the groups. The weight loss effect was also comparable. The patients in the LSG/HHR/HV group achieved significant improvement and prevention of GERD and hiatus hernia (p < 0.001).
CONCLUSION
HV does not appear to have a clinical impact on glycemic control and weight loss. Concomitant HHR with LSG serves to reduce post-LSG GERD.

Identifiants

pubmed: 34081275
doi: 10.1007/s11695-021-05510-x
pii: 10.1007/s11695-021-05510-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3926-3935

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Emile SH, Elfeki H, Elalfy K, et al. Laparoscopic sleeve gastrectomy then and now: an updated systematic review of the progress and short-term outcomes over the last 5 years. Surg Laparosc Endosc Percutan Tech. 2017;27(5):307–17.
pubmed: 28590359 doi: 10.1097/SLE.0000000000000418 pmcid: 28590359
Himpens J, Dapri G, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16:1450–6.
pubmed: 17132410 doi: 10.1381/096089206778869933 pmcid: 17132410
Himpens J, Dobbeleir J, Peeters G. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg. 2010;252:319–24.
pubmed: 20622654 doi: 10.1097/SLA.0b013e3181e90b31 pmcid: 20622654
Braghetto I, Csendes A, Korn O, et al. Gastroesophageal reflux disease after sleeve gastrectomy. Surg Laparosc Endosc Percutan Tech. 2010;20:148–53.
pubmed: 20551811 doi: 10.1097/SLE.0b013e3181e354bc pmcid: 20551811
Stenard F, Iannelli A. Laparoscopic sleeve gastrectomy and gastroesophageal reflux. World J Gastroenterol. 2015;21(36):10348–57.
pubmed: 26420961 pmcid: 4579881 doi: 10.3748/wjg.v21.i36.10348
Wang GJ, Tomasi D, Backus W, et al. Gastric distention activates satiety circuitry in the human brain. Neuroimage. 2008;39(4):1824–31.
pubmed: 18155924 doi: 10.1016/j.neuroimage.2007.11.008 pmcid: 18155924
Kissileff HR, Carretta JC, Geliebter A, et al. Cholecystokinin and stomach distension combine to reduce food intake in humans. Am J Physiol Regul Integr Comp Physiol. 2003;285(5):R992–8.
pubmed: 12920059 doi: 10.1152/ajpregu.00272.2003 pmcid: 12920059
Miranda A, Mickle A, Medda B, et al. Altered mechanosensitive properties of vagal afferent fibers innervating the stomach following gastric surgery in rats. Neuroscience. 2009;162(4):1299–306.
pubmed: 19477237 doi: 10.1016/j.neuroscience.2009.05.042 pmcid: 19477237
Ruiz-Tovar J, Llavero C. Metabolic effect of the hepatic branch of the vagal nerve in one-anastomosis gastric bypass (OAGB). World J Surg. 2020;44(6):1939–44.
pubmed: 32020329 doi: 10.1007/s00268-020-05405-5 pmcid: 32020329
Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996;111:85–92.
pubmed: 8698230 doi: 10.1053/gast.1996.v111.pm8698230 pmcid: 8698230
Seki Y, Kasama K, Hashimoto K. Long-term outcome of laparoscopic sleeve gastrectomy in morbidly obese Japanese patients. Obes Surg. 2016;26:138–45.
pubmed: 25986429 doi: 10.1007/s11695-015-1728-1 pmcid: 25986429
American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13–28.
doi: 10.2337/dc19-S002
Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–5.
pubmed: 19875608 pmcid: 2768219 doi: 10.2337/dc09-9036
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.
pubmed: 23208313 pmcid: 23208313 doi: 10.1038/bmt.2012.244
Berthoud HR. Vagal and hormonal gut-brain communication: from satiation to satisfaction. Neurogastroenterol Motil. 2008;20(Suppl 1):64–72.
pubmed: 18402643 pmcid: 3617963 doi: 10.1111/j.1365-2982.2008.01104.x
Nishi S, Seino Y, Ishida H, et al. Vagal regulation of insulin, glucagon, and somatostatin secretion in vitro in the rat. J Clin Invest. 1987 Apr;79(4):1191–6.
pubmed: 2881948 pmcid: 424307 doi: 10.1172/JCI112936
Shikora S, Toouli J, Herrera MF, et al. Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus. J Obes. 2013;2013:245683.
pubmed: 23984050 pmcid: 3745954 doi: 10.1155/2013/245683
Shikora SA, Toouli J, Herrera MF, et al. Intermittent vagal nerve block for improvements in obesity, cardiovascular risk factors, and glycemic control in patients with type 2 diabetes mellitus: 2-year results of the VBLOC DM2 study. Obes Surg. 2016;26(5):1021–8.
pubmed: 26471783 doi: 10.1007/s11695-015-1914-1 pmcid: 26471783
de Lartigue G. Role of the vagus nerve in the development and treatment of diet-induced obesity. J Physiol. 2016;594(20):5791–815.
pubmed: 26959077 pmcid: 5063945 doi: 10.1113/JP271538
Baccaro LM, Lucas CN, Zandomeni MR, et al. Anatomy of the anterior vagus nerve: an anatomic description and its application in surgery. Anat Physiol. 2013;3:2.
Nishizawa M, Nakabayashi H, Uehara K, et al. Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways. Am J Physiol Endocrinol Metab. 2013;305(3):E376–87.
pubmed: 23715725 doi: 10.1152/ajpendo.00565.2012 pmcid: 23715725
Iwasaki Y, Sendo M, Dezaki K, et al. GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose. Nat Commun. 2018;9(1):113.
pubmed: 29317623 pmcid: 5760716 doi: 10.1038/s41467-017-02488-y
Izumida Y, Yahagi N, Takeuchi Y, et al. Glycogen shortage during fasting triggers liver-brain-adipose neurocircuitry to facilitate fat utilization. Nat Commun. 2013;4:2316.
pubmed: 23939267 doi: 10.1038/ncomms3316 pmcid: 23939267
Haruta H, Kasama K, Ohta M, et al. Long-term outcomes of bariatric and metabolic surgery in Japan: results of a multi-institutional survey. Obes Surg. 2017;27(3):754–62.
pubmed: 27631329 doi: 10.1007/s11695-016-2361-3 pmcid: 27631329
Liu T, Zhong MW, Liu Y, et al. Effects of sleeve gastrectomy plus trunk vagotomy compared with sleeve gastrectomy on glucose metabolism in diabetic rats. World J Gastroenterol. 2017;23(18):3269–78.
pubmed: 28566886 pmcid: 5434432 doi: 10.3748/wjg.v23.i18.3269
Okafor PN, Lien C, Bairdain S, et al. Effect of vagotomy during Roux-en-Y gastric bypass surgery on weight loss outcomes. Obes Res Clin Pract. 2015;9(3):274–80.
pubmed: 25458372 doi: 10.1016/j.orcp.2014.09.005 pmcid: 25458372
Qiu NC, Zhang Q, Song X, et al. Impact of the hepatic branch of the vagus and Roux-en-Y gastric bypass on the hypoglycemic effect and glucagon-like peptide-1 in rats with type 2 diabetes mellitus. J Surg Res. 2014;191(1):123–9.
pubmed: 24768143 doi: 10.1016/j.jss.2014.03.062 pmcid: 24768143
Cummings DE. Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav. 2006;89(1):71–84.
pubmed: 16859720 doi: 10.1016/j.physbeh.2006.05.022 pmcid: 16859720
Kamiji MM, Troncon LE, Antunes-Rodrigues J, et al. Ghrelin and PYY(3–36) in gastrectomized and vagotomized patients: relations with appetite, energy intake and resting energy expenditure. Eur J Clin Nutr. 2010;64(8):845–52.
pubmed: 20485299 doi: 10.1038/ejcn.2010.88 pmcid: 20485299
Williams DL, Grill HJ, Cummings DE, et al. Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology. 2003;144(12):5184–7.
pubmed: 14525914 doi: 10.1210/en.2003-1059 pmcid: 14525914
Gu L, Lin K, Du N, et al. Differences in the effects of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass on gut hormones: systematic and meta-analysis. Surg Obes Relat Dis. 2020:S1550. 7289(20):30608–0
Yada T, Dezaki K, Sone H, et al. Ghrelin regulates insulin release and glycemia: physiological role and therapeutic potential. Curr Diabetes Rev. 2008;4(1):18–23.
pubmed: 18220691 doi: 10.2174/157339908783502352 pmcid: 18220691
Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009;106(7):2365–70.
pubmed: 19164560 pmcid: 2629490 doi: 10.1073/pnas.0812600106
Su DW, Wei WW, Yao RR, et al. Research on sleeve gastrectomy for the treatment of rats with type 2 diabetes mellitus and the regulation of ghrelin and intestinal lesions. Eur Rev Med Pharmacol Sci. 2020;24(20):10653–62.
pubmed: 33155223 pmcid: 33155223
Stefanidis D, Hope WW, Kohn GP, et al. Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc. 2010;24(11):2647–69.
pubmed: 20725747 doi: 10.1007/s00464-010-1267-8 pmcid: 20725747
Nocca D, Krawczykowsky D, Bomans B, et al. A prospective multicenter study of 163 sleeve gastrectomies: results at 1 and 2 years. Obes Surg. 2008;18(5):560–5.
pubmed: 18317859 doi: 10.1007/s11695-007-9288-7 pmcid: 18317859
Arias E, Martínez PR. Ka Ming Li V, Szomstein S, Rosenthal RJ. Mid-term follow-up after sleeve gastrectomy as a final approach for morbid obesity. Obes Surg. 2009;19(5):544–8.
pubmed: 19280267 doi: 10.1007/s11695-009-9818-6 pmcid: 19280267
Menenakos E, Stamou KM, Albanopoulos K, et al. Laparoscopic sleeve gastrectomy performed with intent to treat morbid obesity: a prospective single-center study of 261 patients with a median follow-up of 1 year. Obes Surg. 2010;20(3):276–82.
pubmed: 19636644 doi: 10.1007/s11695-009-9918-3
Quero G, Fiorillo C, Dallemagne B, et al. The causes of gastroesophageal reflux after laparoscopic sleeve gastrectomy: quantitative assessment of the structure and function of the esophagogastric junction by magnetic resonance imaging and high-resolution manometry. Obes Surg. 2020;30(6):2108–17.
pubmed: 32207049 doi: 10.1007/s11695-020-04438-y pmcid: 32207049
Soricelli E, Iossa A, Casella G, et al. Sleeve gastrectomy and crural repair in obese patients with gastroesophageal reflux disease and/or hiatal hernia. Surg Obes Relat Dis. 2013;9:356–61.
pubmed: 22867558 doi: 10.1016/j.soard.2012.06.003 pmcid: 22867558
Mahawar KK, Carr WR, Jennings N, et al. Simultaneous sleeve gastrectomy and hiatus hernia repair: a systematic review. Obes Surg. 2015;25(1):159–66.
pubmed: 25348434 doi: 10.1007/s11695-014-1470-0 pmcid: 25348434
Watson DI, Thompson SK, Devitt PG, et al. Laparoscopic repair of very large hiatus hernia with sutures versus absorbable mesh versus nonabsorbable mesh: a randomized controlled trial. Ann Surg. 2015;261(2):282–9.
pubmed: 25119120 doi: 10.1097/SLA.0000000000000842 pmcid: 25119120

Auteurs

Akihiko Sano (A)

Weight Loss and Metabolic Surgery Center, Yotsuya Medical Cube, 7-7 Nibancho, Chiyoda-ku, Tokyo, 102-0084, Japan.
Department of General Surgical Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.

Yosuke Seki (Y)

Weight Loss and Metabolic Surgery Center, Yotsuya Medical Cube, 7-7 Nibancho, Chiyoda-ku, Tokyo, 102-0084, Japan. y-seki@mcube.jp.

Kazunori Kasama (K)

Weight Loss and Metabolic Surgery Center, Yotsuya Medical Cube, 7-7 Nibancho, Chiyoda-ku, Tokyo, 102-0084, Japan.

Taiki Nabekura (T)

Weight Loss and Metabolic Surgery Center, Yotsuya Medical Cube, 7-7 Nibancho, Chiyoda-ku, Tokyo, 102-0084, Japan.

Yoshimochi Kurokawa (Y)

Weight Loss and Metabolic Surgery Center, Yotsuya Medical Cube, 7-7 Nibancho, Chiyoda-ku, Tokyo, 102-0084, Japan.

Yasunari Ubukata (Y)

Department of General Surgical Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.

Nobuhiro Nakazawa (N)

Department of General Surgical Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.

Keigo Hara (K)

Department of General Surgical Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.

Makoto Sakai (M)

Department of General Surgical Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.

Makoto Sohda (M)

Department of General Surgical Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.

Ken Shirabe (K)

Department of General Surgical Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.

Hiroshi Saeki (H)

Department of General Surgical Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH